About Heartflow, Inc. Common Stock
https://www.heartflow.comHeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases worldwide. Its HeartFlow Platform uses AI and computational fluid dynamics to creates a personalized 3D model of a patient's heart from a single coronary computed tomography angiography, a specialized type of scan that provides detailed images of the heart's arteries.
CEO
John Farquhar
Compensation Summary
(Year )
ETFs Holding This Stock
VTS.AX
Weight:0.00%
Shares:509.06K
XSU.TO
Weight:0.02%
Shares:451.20K
IWM
Weight:0.02%
Shares:451.20K
Summary
Showing Top 3 of 83
Ratings Snapshot
Rating : C-
Most Recent Analyst Grades
Grade Summary
Showing Top 3 of 3
Price Target
Institutional Ownership
BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC
Shares:12.45M
Value:$435.44M
WELLINGTON MANAGEMENT GROUP LLP
Shares:4.88M
Value:$170.7M
BAILLIE GIFFORD & CO
Shares:3.01M
Value:$105.15M
Summary
Showing Top 3 of 74
About Heartflow, Inc. Common Stock
https://www.heartflow.comHeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases worldwide. Its HeartFlow Platform uses AI and computational fluid dynamics to creates a personalized 3D model of a patient's heart from a single coronary computed tomography angiography, a specialized type of scan that provides detailed images of the heart's arteries.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $46.28M ▲ | $50.51M ▲ | $-50.85M ▼ | -109.89% ▼ | $0.52 ▲ | $-21.86M ▼ |
| Q2-2025 | $43.42M ▲ | $46.49M ▲ | $-9.2M ▲ | -21.18% ▲ | $-0.11 ▲ | $-371K ▲ |
| Q1-2025 | $37.2M ▲ | $45.44M ▲ | $-32.34M ▼ | -86.94% ▼ | $-0.35 ▲ | $-25.16M ▼ |
| Q2-2024 | $31.05M ▲ | $38.02M ▲ | $-23.38M ▼ | -75.28% ▲ | $-0.37 ▼ | $-15.33M ▼ |
| Q1-2024 | $26.84M | $35.48M | $-20.93M | -77.98% | $-0.33 | $-12.89M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $291.17M ▲ | $364.4M ▲ | $109.83M ▼ | $254.57M ▲ |
| Q2-2025 | $80.21M ▼ | $159.36M ▼ | $1.05B ▼ | $-894.79M ▼ |
| Q1-2025 | $109.79M | $184.44M | $1.07B | $-889M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-50.85M ▼ | $-2.96M ▲ | $-1.24M ▼ | $214.94M ▲ | $210.96M ▲ | $-4.19M ▲ |
| Q2-2025 | $-9.2M ▲ | $-27.3M ▼ | $-790K ▲ | $-1.77M ▼ | $-29.58M ▼ | $-28.09M ▼ |
| Q1-2025 | $-32.34M ▼ | $-13.17M ▲ | $-1.1M ▲ | $72.92M ▲ | $58.42M ▲ | $-14.27M ▲ |
| Q2-2024 | $-23.38M ▼ | $-22.56M ▼ | $-1.26M ▲ | $326K ▲ | $-23.59M ▲ | $-23.82M ▲ |
| Q1-2024 | $-20.93M | $-22.13M | $-1.75M | $77K | $-23.8M | $-23.88M |
CEO
John Farquhar
Compensation Summary
(Year )
ETFs Holding This Stock
VTS.AX
Weight:0.00%
Shares:509.06K
XSU.TO
Weight:0.02%
Shares:451.20K
IWM
Weight:0.02%
Shares:451.20K
Summary
Showing Top 3 of 83
Ratings Snapshot
Rating : C-
Most Recent Analyst Grades
Grade Summary
Showing Top 3 of 3
Price Target
Institutional Ownership
BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC
Shares:12.45M
Value:$435.44M
WELLINGTON MANAGEMENT GROUP LLP
Shares:4.88M
Value:$170.7M
BAILLIE GIFFORD & CO
Shares:3.01M
Value:$105.15M
Summary
Showing Top 3 of 74